drugset / Trial / NCT00633191

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

NCT00633191 ↗

Phase 1/2 Completed 14 enrolled Immunsystem AB
NaSingle-groupOpen-labelPrevention

Summary

Hypothesis: Daily gargling with specific avian antibodies against Pseudomonas aeruginosa will prevent infections with this bacteria in patients with Cystic fibrosis (CF).

Timeline

Start
2003-11
Primary completion
2012-12
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Anti-pseudomonas IgY Protein / enzyme biologic 5 unknown Other